Talking therapy tested to ease fear after cancer immunotherapy ends
NCT ID NCT04761328
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether cognitive behavioral therapy (CBT) can reduce fear, anxiety, and depression in cancer patients who are distressed about stopping immunotherapy. One hundred adults who have finished immunotherapy will receive CBT sessions. The goal is to see if this talking therapy improves quality of life and emotional well-being.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cognitive behavioral therapy
- What this could lead to
- If it works, this could offer a way to ease emotional distress and improve quality of life for cancer patients finishing immunotherapy.
- What could go wrong
- This is a small, early-stage study with no control group, so results may not be conclusive. The therapy may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UPMC Hillman Cancer Centers
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare
- Can simple positive activities boost Well-Being in cancer care?